Accessibility Menu
Ingen Technologies logo

Ingen Technologies(OTC) IGNT

Market Cap$4.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-96%
1 Year+4,600%
1 Month+114%
$0.00
+0.00%
+0.00Today
Ingen Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-02
Ingen Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+113.64%USD 0.002026-05-14
1 month+113.64%USD 0.002026-05-14
3 month+4,600%USD 0.002026-03-30
Year to date+4,600%USD 0.002025-12-16
1 year+4,600%USD 0.002025-01-30
3 year+4,600%USD 0.002023-06-23
5 year-96.08%USD 0.002021-07-02
Since inception-100%USD 111,047,827.672005-12-08

Ingen Technologies Financials at a Glance

Market Cap

$4.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$257.25K

Net Income (TTM)

-$2.96M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.60 (High)

Price

$0.00

Volume

433

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2013

IGNT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ingen Technologies

Ingen Technologies, Inc. is a manufacturer of respiratory medical devices, specializing in products such as oxygen flow meters and nasal cannulas. Founded in 1999 and headquartered in Riverside, California, the company operates under the trademark names Oxyview and Smart Nasal Cannula.

Products and Services
  • Oxygen flow meters designed for accurate measurement
  • Nasal cannulas that enhance patient comfort and usability
  • Innovative respiratory solutions aimed at improving healthcare outcomes
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased demand for respiratory devices due to aging populations
  • Strategic partnerships may enhance product distribution and visibility
Financial Highlights
  • Recent quarterly revenue of 5,402, indicating potential for recovery
  • Gross profit margin of 89.37% reflects strong product demand
  • Operating expenses have been managed, showing a focus on efficiency
Ingen Technologies, Inc. operates in the medical devices sector, focusing on respiratory solutions that are critical in healthcare settings. The company has shown resilience in its financial performance, with a gross profit margin that suggests strong demand for its products. The recent quarterly revenue indicates a potential recovery phase, which may attract investor interest. The growth outlook remains positive, driven by an aging population and increasing healthcare needs. Strategic partnerships and market expansion efforts are expected to further enhance the company's position in the industry. Overall, Ingen Technologies, Inc. presents a compelling opportunity for investors looking to engage with a company poised for growth in the healthcare sector.
AI Generated • Aug 15, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Riverside, CA 92503, US

IGNT Financials

Key Financial Metrics (TTM)

Gross Margin

95.70%

Operating Margin

-4821.23%

Net Income Margin

-7460.38%

Return on Equity

0.02%

Return on Capital

N/A

Return on Assets

-317.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

89.60M

Volume

433

Avg. Volume

39.30K

Financials (TTM)

Gross Profit

$89.08K

Operating Income

-$1.89M

EBITDA

-$1.85M

Operating Cash Flow

-$641.64K

Capital Expenditure

-$238.17K

Free Cash Flow

-$879.81K

Cash & ST Invst.

$113.00

Total Debt

$3.24M

Ingen Technologies Performance Analysis

Ingen Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12007-08-311.6%
Q22007-11-30-36.5%
Q32008-02-29-19.7%
Q22008-11-30N/A
Ingen Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12007-08-31N/A
Q22007-11-30N/A
Q32008-02-29N/A
Q22008-11-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2008YOY CHG

Revenue

$5.40K

-95.3%

Gross Profit

$4.83K

-22.3%

Gross Margin

89.37%

N/A

Market Cap

$4.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$27.10

N/A

Employees

155

N/A

Net Income

-$1.73M

-22.3%

EBITDA

-$750.04K

-83.5%

Quarterly Fundamentals

Name
Q2 2008YOY CHG

Total Cash

$113.00

-52.5%

Total Debt

$3.24M

+414.0%

Accounts Receivable

$176.00

N/A

Inventory

$74.14K

-13.4%

Long Term Debt

$280.93K

-47.2%

Short Term Debt

$2.96M

+2897.1%

Return on Assets

-3.18%

N/A

Return on Invested Capital

9.42%

N/A

Free Cash Flow

-$69.39K

+81.9%

Operating Cash Flow

-$69.39K

+81.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARDSAridis Pharmaceuticals, Inc.
$0.00+0.00%
LIFSLife Stem Genetics Inc.
$0.00+0.00%
AFIBAcutus Medical, Inc.
$0.00+0.00%
KKURChromoCure, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.83+0.06%
IBITiShares Bitcoin Trust
$41.19+0.06%
SPCXSpace Exploration Technologies
$130.74-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.82-0.04%

Questions About IGNT

What is the current price of Ingen Technologies?

Ingen Technologies is trading at $0.00 per share.

What is the 52-week range for Ingen Technologies?

Over the past 52 weeks, Ingen Technologies has traded between $0.00 and $0.00.

How much debt does Ingen Technologies have?

Ingen Technologies total debt is unavailable.

How much cash does Ingen Technologies have on hand?

Ingen Technologies does not have cash on hand data available.

What is Ingen Technologies’s dividend yield?

Ingen Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.